“…Resident fibroblasts and especially PSCs are major sources of CAFs in pancreatic cancer [ 21 , 22 , 23 ]. Furthermore, adipocytes, pericytes, monocytes, endothelial cells, and bone marrow-derived or adipose-derived mesenchymal stem cells (MSCs) can differentiate into CAFs ( Figure 1 ) [ 24 , 25 , 26 , 27 ]. Cultured MSCs themselves exhibit a high cellular plasticity and capacity to undergo osteogenic, adipogenic, myogenic, and chondrogenic differentiation [ 28 ].…”